GoldenGolden
Advanced Search
Cold Genesys

Cold Genesys

Cold Genesys is a privately-held, immunotherapy based biopharmaceutical company

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

March 2019
Cold Genesys raises a $22,000,000 series C round from ORI Capital, ORI Healthcare Fund LP and Perseverance Capital Management.

Funding rounds

People

Name
Role
LinkedIn

Steven Hsu

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.